John F. Paolini
2021
In 2021, John F. Paolini earned a total compensation of $2M as Senior Vice President and Chief Medical Officer at Kiniksa Pharmaceuticals, Ltd..
Compensation breakdown
| Non-Equity Incentive Plan | $242,863 |
|---|---|
| Option Awards | $996,606 |
| Salary | $456,393 |
| Stock Awards | $321,368 |
| Other | $11,600 |
| Total | $2,028,830 |
Paolini received $996.6K in option awards, accounting for 49% of the total pay in 2021.
Paolini also received $242.9K in non-equity incentive plan, $456.4K in salary, $321.4K in stock awards and $11.6K in other compensation.
Rankings
In 2021, John F. Paolini's compensation ranked 5,999th out of 12,415 executives tracked by ExecPay. In other words, Paolini earned more than 51.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,999 out of 12,415 | 52nd |
Division Manufacturing | 2,543 out of 5,505 | 54th |
Major group Chemicals And Allied Products | 1,112 out of 2,375 | 53rd |
Industry group Drugs | 990 out of 2,096 | 53rd |
Industry Pharmaceutical Preparations | 713 out of 1,546 | 54th |
Source: SEC filing on April 27, 2023.
Paolini's colleagues
We found one more compensation record of an executive who worked with John F. Paolini at Kiniksa Pharmaceuticals, Ltd. in 2021.
2021
Sanj Patel
Kiniksa Pharmaceuticals, Ltd.